The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SEPN · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
LYRA · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | RSCF | AVTX | SEPN | LYRA |
|---|---|---|---|---|
| Moat Score (0–100) | 39 (highest) | 39 (highest) | 39 (highest) | 39 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 13 | 20 | 60 (highest) | 57 |
| Pricing power | 94 (highest) | 70 | — | — |
| Returns on capital | 9 (highest) | 7 | 0 | 0 |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 55 (highest) | 55 (highest) |
| Capital allocation | 24 | 44 (highest) | 42 | 44 (highest) |
| 245% above value if growth stopped today | No price data | No price data | No price data | |
| Market cap | $3.4M | $341M | $1.5B | $922939 |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2023 | FY2025 | FY2025 | FY2025 |